Use of oral N-acetylcysteine for protection of melanocytic nevi against UV-induced oxidative stress: Towards a novel paradigm for melanoma chemoprevention

Clinical Cancer Research

Volumn 15, Issue 23, 2009, Pages 7434-7440

  Goodson, Agnessa Gadeliya ^a   Cotter, Murray A ^a   Cassidy, Pamela ^a,b,c   Wade, Mark ^c   Florell, Scott R ^a   Liu, Tong ^c   Boucher, Kenneth M ^b,c   Grossman, Douglas ^a,b,c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CYSTEINE; GLUTATHIONE; REACTIVE OXYGEN METABOLITE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER PREVENTION; CANCER RISK; CHEMOPROPHYLAXIS; CLINICAL TRIAL; FEMALE; GLUTATHIONE METABOLISM; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOCYTIC NEVUS; MELANOMA; NAUSEA; OXIDATIVE STRESS; PRIORITY JOURNAL; PRURITUS; SINGLE DRUG DOSE; SKIN CARCINOGENESIS; SUN EXPOSURE; ULTRAVIOLET IRRADIATION;

ACETYLCYSTEINE; ADMINISTRATION, ORAL; ADULT; AGED; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; CYSTEINE; FEMALE; GLUTATHIONE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEVUS, PIGMENTED; OXIDATIVE STRESS; RISK; SKIN NEOPLASMS; TIME FACTORS; ULTRAVIOLET RAYS;

EID: 73149093893     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-1890     Document Type: Article

References (45)

1. Tsao H, Atkins MB, Sober AJ. Management of cutaneous melanoma. N Engl J Med 2004;351: 998-1012.
2. Crucioli V, Stilwell J. The histogenesis of malignant melanoma in relation to pre-existing pigmented lesions. J Cutan Pathol 1982;9:396-404.
3. Robinson WA, Lemon M, Elefanty A, Harrison-Smith M, Markham N, Norris D. Human acquired nevi are clonal. Melanoma Res 1998;8:499-503.
4. Kelly JW, Rivers JK, MacLennan R, Harrison S, Lewis AE, Tate BJ. Sunlight: a major factor associated with the development of melanocytic nevi in Australian schoolchildren. J Am Acad Dermatol 1994;30:40-8.
5. Gilchrest BA, Eller MS, Geller AC, Yaar M. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med 1999;340:1341-8.
6. Bigby M. The sunscreen and melanoma controversy. Arch Dermatol 1999;135:1526-7.
7. Autier P, Boniol M, Dore JF. Sunscreen use and increased duration of intentional sun exposure: still a burning issue. Int J Cancer 2007;121:1-5.
8. Lademann J, Schanzer S, Richter H, et al. Sunscreen application at the beach. J Cosmet Dermatol 2004;3:62-8.
9. Herrling T, Jung K, Fuchs J. Measurements of UV-generated free radicals/reactive oxygen species (ROS) in skin. Spectrochim Acta A Mol Biomol Spectrosc 2006;63:840-5.
10. Farmer PJ, Gidanian S, Shahandeh B, Di Bilio AJ, Tohidian N, Meyskens FL. Melanin as a target for melanoma chemotherapy: pro-oxidant effect of oxygen and metals on melanoma viability. Pigment Cell Res 2003;16:273-9.
11. Bruner SD, Norman DP, Verdine GL. Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA. Nature 2000;403:859-66.
12. Meyskens FL, Jr., Farmer P, Fruehauf JP. Redox regulation in human melanocytes and melanoma. Pigment Cell Res 2001;14:148-54.
13. Grammatico P, Maresca V, Roccella F, et al. Increased sensitivity to peroxidizing agents is correlated with an imbalance of antioxidants in normal melanocytes from melanoma patients. Exp Dermatol 1998;7:205-12.
14. de Souza GA, Godoy LM, Teixeira VR, et al. Proteomic and SAGE profiling of murine melanoma progression indicates the reduction of proteins responsible for ROS degradation. Proteomics 2006;6:1460-70.
15. Govindarajan B, Sligh JE, Vincent BJ, et al. Overexpression of Akt converts radial growth melanoma to vertical growth melanoma. J Clin Invest 2007;117:719-29.
16. Reddy KK, Lefkove B, Chen LB, et al. The antidepressant sertraline downregulates Akt and has activity against melanoma cells. Pigment Cell Melanoma Res 2008;21:451-6.
17. Samokhvalov A, Hong L, Liu Y, et al. Oxidation potentials of human eumelanosomes and pheomelanosomes. Photochem Photobiol 2005;81: 145-8.
18. Kadekaro AL, Kavanagh R, Kanto H, et al. α-Melanocortin and endothelin-1 activate antiapoptotic pathways and reduce DNA damage in human melanocytes. Cancer Res 2005;65: 4292-9.
19. Landi MT, Bauer J, Pfeiffer RM, et al. MC1R germline variants confer risk for BRAF-mutant melanoma. Science 2006;313:521-2.
20. Wood SR, Berwick M, Ley RD, Walter RB, Setlow RB, Timmins GS. UV causation of melanoma in Xiphophorus is dominated by melanin photosensitized oxidant production. Proc Natl Acad Sci U S A 2006;103:4111-5.
21. Zyrek-Betts J, Micale M, Lineen A, et al. Malignant blue nevus with lymph node metastases. J Cutan Pathol 2008;35:651-7.
22. Pashaei S, Li L, Zhang H, et al. Concordant loss of heterozygosity of DNA repair gene, hOGG1, in melanoma in situ and atypical melanocytic hyperplasia. J Cutan Pathol 2008;35:525-31.
23. Cotter MA, Thomas J, Cassidy P, et al. N-acetylcysteine protects melanocytes against oxidative stress/damage and delays onset of ultraviolet-induced melanoma in mice. Clin Cancer Res 2007;13:5952-8.
24. Maxwell SR. Prospects for the use of antioxidant therapies. Drugs 1995;49:345-61.
25. Physician's Desk Reference (PDR). 2007. 1031-4.
26. Demedts M, Behr J, Buhl R, et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2005;353:2229-42.
27. Marenzi G, Assanelli E, Marana I, et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 2006; 354:2773-82.
28. Kang S, Chung JH, Lee JH, et al. Topical N-acetyl cysteine and genistein prevent ultravioletlight-induced signaling that leads to photoaging in human skin in vivo. J Invest Dermatol 2003; 120:835-41.
29. Florell SR, Smoller BR, Boucher KM, et al. Sampling of melanocytic nevi for research purposes: a prospective, pilot study to determine effect on diagnosis. J Am Acad Dermatol 2008;59: 814-21.
30. Yan H, Thomas J, Liu T, et al. Induction of melanoma cell apoptosis and inhibition of tumor growth using a cell-permeable Survivin antagonist. Oncogene 2006;25:6968-74.
31. Fahey RC, Newton GL. Determination of lowmolecular-weight thiols using monobromobimane fluorescent labeling and high-performance liquid chromatography. Methods Enzymol 1987; 143:85-96.
32. Yim CY, Hibbs JB, McGregor JR, Galinsky RE, Samlowski WE. Use of N-acetyl cysteine to increase intracellular glutathione during the induction of antitumor responses by IL-2. J Immunol 1994;152:5796-805.
33. Linos E, Swetter SM, Cockburn MG, Colditz GA, Clarke CA. Increasing burden of melanoma in the United States. J Invest Dermatol 2009;129: 1666-74.
34. Emdin M, Pompella A, Paolicchi A. γ-Glutamyl-transferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation 2005;112:2078-80.
35. Turgut O, Yilmaz A, Yalta K, Karadas F, Birhan Yilmaz M. γ-Glutamyltransferase is a promising biomarker for cardiovascular risk. Med Hypotheses 2006;67:1060-4.
36. Bureau I, Gueux E, Mazur A, Rock E, Roussel AM, Rayssiguier Y. Female rats are protected against oxidative stress during copper deficiency. J Am Coll Nutr 2003;22:239-46.
37. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007;297:842-57.
38. Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for lung cancer and for intervention effects in CARET, the β-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 1996;88:1550-9.
39. Hercberg S, Ezzedine K, Guinot C, et al. Antioxidant supplementation increases the risk of skin cancers in women but not in men. J Nutr 2007;137:2098-105.
40. Francis SO, Mahlberg MJ, Johnson KR, Ming ME, Dellavalle RP. Melanoma chemoprevention. J Am Acad Dermatol 2006;55:849-61.
41. Hsu S. Green tea and the skin. J Am Acad Dermatol 2005;52:1049-59.
42. Nihal M, Ahmad N, Mukhtar H, Wood GS. Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gallate on human melanoma: possible implications for the chemoprevention of melanoma. Int J Cancer 2005;114:513-21.
43. Taniguchi S, Fujiki H, Kobayashi H, et al. Effect of (-)-epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines. Cancer Lett 1992;65: 51-4.
44. Zheng W, Doyle TJ, Kushi LH, Sellers TA, Hong CP, Folsom AR. Tea consumption and cancer incidence in a prospective cohort study of postmenopausal women. Am J Epidemiol 1996;144:175-82.
45. Nordlund JJ, Kirkwood J, Forget BM, et al. Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects. Cancer Res 1985;45: 1855-61.